Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ASBP Aspire Biopharma Holdings Inc.

Closed 04-20 16:00:00 EDT

0.2619

-0.0078

-2.89%

盘后0.2750

+0.0131+5.00%

19:59 EDT

High0.3300	Low0.2200	Vol9.29M
Open0.2860	D1 Closing0.2697	Amplitude40.79%
Mkt Cap1.32M	Tradable Cap803.01K	Total Shares5.02M
T/O2.60M	T/O Rate302.88%	Tradable Shares3.07M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":0.2619,"timestamp":1776715200000,"preClose":0.2697,"halted":0,"volume":9286481,"hourTrading":{"tag":"盘后","latestPrice":0.275,"preClose":0.2619,"latestTime":"19:59 EDT","volume":285649,"amount":77350.760099,"timestamp":1776729577238,"change":0.0131,"changeRate":0.050019,"amplitude":0.090111},"delay":0,"changeRate":-0.028921023359288,"floatShares":3066100,"shares":5024142,"eps":-16.375631,"marketStatus":"Closed","change":-0.0078,"latestTime":"04-20 16:00:00 EDT","open":0.286,"high":0.33,"low":0.22,"amount":2604440.028855,"amplitude":0.407861,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-16.375631,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1776758400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2697,"preHourTrading":{"tag":"盘前","latestPrice":0.2745,"preClose":0.2697,"latestTime":"09:29 EDT","volume":778242,"amount":210053.86625472,"timestamp":1776691743286,"change":0.0048,"changeRate":0.017798,"amplitude":0.129774},"postHourTrading":{"tag":"盘后","latestPrice":0.275,"preClose":0.2619,"latestTime":"19:59 EDT","volume":285649,"amount":77350.760099,"timestamp":1776729577238,"change":0.0131,"changeRate":0.050019,"amplitude":0.090111},"volumeRatio":1.219196},"requestUrl":"/m/hq/s/ASBP/tweets","defaultTab":"tweets","newsList":[{"id":"2628290517","title":"Aspire Biopharma closes final tranche of $21M private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2628290517","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628290517?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:15","pubTimestamp":1776694512,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) closed the second and final tranche of the private placement announced on February 11 for the purchase and sale of 26,250 s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-closes-final-tranche-of-21m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-closes-final-tranche-of-21m-private-placement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628728718","title":"Aspire Biopharma secures commitment letter for up to $22.5 million DCS acquisition loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2628728718","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628728718?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:31","pubTimestamp":1776688290,"startTime":"0","endTime":"0","summary":"Aspire Biopharma entered a letter of intent dated April 15, 2026 to buy Dura Control Systems  for USD 30 million in cash.DCS is described as a global automotive driver control systems supplier with FY2025 revenue above USD 200 million.DCS delivered more than USD 20 million of adjusted EBITDA on that revenue base, on an unaudited basis.Aspire secured a commitment letter for a senior secured credit facility of up to USD 22.5 million to finance the proposed acquisition.Facility is structured as a five-year term loan priced at 325 basis points over one-month term SOFR.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL2s1KSV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628206688","title":"Buzz Bomb brand ambassador to attempt fastest 100-mile treadmill run","url":"https://stock-news.laohu8.com/highlight/detail?id=2628206688","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628206688?lang=en_us&edition=fundamental","pubTime":"2026-04-17 20:15","pubTimestamp":1776428144,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) announced that elite ultra-marathoner and BUZZ BOMB Global Brand Ambassador Ashley Paulson will attempt to shatter the fema...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/buzz-bomb-brand-ambassador-to-attempt-fastest-100-mile-treadmill-run-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/buzz-bomb-brand-ambassador-to-attempt-fastest-100-mile-treadmill-run-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628724546","title":"Aspire Biopharma stockholders approve charter amendments for potential reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2628724546","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628724546?lang=en_us&edition=fundamental","pubTime":"2026-04-17 03:23","pubTimestamp":1776367392,"startTime":"0","endTime":"0","summary":"Aspire Biopharma stockholders held a special meeting on April 10, 2026.Shareholders backed a charter amendment authorizing a reverse stock split, with a ratio range of 1-for-5 to 1-for-500 set at board discretion within one year.Approval was also granted for issuance of common shares issuable on conversion of Series A Convertible Preferred Stock, including conversion shares above the 19.99% threshold, with a conversion floor price set at 20% of the Minimum Price.Shareholders also approved an amendment to increase authorized common shares to 700,000,000, alongside authority to adjourn the meeting if needed to solicit additional proxies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL3GsSHq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627750218","title":"Aspire Biopharma Holdings Inc - Enters Letter of Intent to Buy Dura Driver Control Systems - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627750218","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627750218?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:35","pubTimestamp":1776342900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nFWN40Z0UQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627184072","title":"Aspire Biopharma signs LOI to buy automotive supplier Dura Driver Control Systems for $30 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627184072","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627184072?lang=en_us&edition=fundamental","pubTime":"2026-04-16 20:30","pubTimestamp":1776342629,"startTime":"0","endTime":"0","summary":"Aspire Biopharma entered a letter of intent to acquire Dura Driver Control Systems, a tier-one automotive driver control systems supplier.Deal terms call for Aspire to buy 100% of DCS for USD 30 million in cash, subject to due diligence.DCS generated more than USD 200 million in FY2025 revenue, based on unaudited results.Adjusted EBITDA exceeded USD 20 million in FY2025, with net income above USD 17 million.DCS operates 11 facilities globally and holds more than 310 patents, supporting over 150 vehicle platforms.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLc2L7Wg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627466231","title":"BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI Systems","url":"https://stock-news.laohu8.com/highlight/detail?id=2627466231","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627466231?lang=en_us&edition=fundamental","pubTime":"2026-04-16 01:35","pubTimestamp":1776274543,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Nike, PNC Financia, OSI SystemsWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nL6N40Y0QD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EGBN","BAC","NVDW","WULF","DTIL","STNE","UNP","BORR","HOOD","NVDL","PNC","NVDD","NKE","KMX","AVGW","CSX","WINA","NRXP","TNGX","NEM","QUBT","SPRY","OSIS","NXL","BIRD","GTLB","FNB","AEO","IONQ","NVDY","ABUS","NVDA","SYRE","ASBP","NOV","LLY","AVGO","RGTI","RVMD","TEM","SNVD.UK","TE","ALLO","LLYX","PDSB","GLOO","FHN","ANV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627028193","title":"Aspire subsidiary Buzz Bomb signs Interwest brokerage deal for Intermountain West expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2627028193","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627028193?lang=en_us&edition=fundamental","pubTime":"2026-04-15 20:00","pubTimestamp":1776254457,"startTime":"0","endTime":"0","summary":"Aspire Biopharma subsidiary Buzz Bomb Caffeine entered sales and marketing brokerage agreement with Interwest Brokerage to expand retail distribution.Interwest will lead BUZZ BOMB sales, marketing, and distribution across Utah, Idaho, and Montana.Deal targets faster penetration in grocery, convenience, and alternate channels across Intermountain West.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL7y7NSD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627281659","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2627281659","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627281659?lang=en_us&edition=fundamental","pubTime":"2026-04-15 19:59","pubTimestamp":1776254342,"startTime":"0","endTime":"0","summary":"HeartBeam  shares were down 27% in Wednesday premarket activity, a day after the company said it priced a public offering of 12.5 million of its common shares for $10 million in total gross proceeds.Aspire Biopharma  stock was about 27% lower after the company said it signed a letter of intent to acquire Driver Controls Systems' business unit of Firefish Topco.BRP  shares were down over 23% after the company said overnight it was suspending its full-year 2027 guidance following a recent amendment to US rules for tariffs on steel, aluminum, and copper imports, which became effective earlier this month.TeraWulf  stock was 7.5% lower after the company said late Tuesday that it priced a public offering of 47.4 million shares at $19 each for gross proceeds of about $900 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WULX","DOO","BK4190","ASBP","BK4595","BK4023","BEAT","BK4007","WULF","BK4600","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627830972","title":"Aspire Biopharma signs LOI to buy Firefish Topco’s Driver Controls Systems unit for $30 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627830972","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627830972?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:34","pubTimestamp":1776249267,"startTime":"0","endTime":"0","summary":"Aspire Biopharma entered non-binding letter of intent dated April 15, 2026 to acquire 100% of Driver Controls Systems business unit of Firefish Topco.LOI sets enterprise valuation at $30 million on cash-free, debt-free basis, payable in cash at closing with customary adjustments.Transaction includes $3.5 million break-up fee payable by either side under specified circumstances.Sellers agreed to 30-day no-shop period, subject to possible extension.Post-closing plan calls for Lakewood & Company to provide management services for DCS, subject to separate definitive agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electron","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL3ln5w5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627746283","title":"Aspire Biopharma Holdings Inc - Deal Valued at $30 Mln, Payable in Cash at Closing - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627746283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627746283?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:31","pubTimestamp":1776249078,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0BG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627628372","title":"Aspire Biopharma Holdings Inc - Enters Non-Binding Loi to Buy 100% of Driver Controls Systems From Firefish Topco - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627628372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627628372?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:31","pubTimestamp":1776249078,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0BG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627283793","title":"Aspire Biopharma Holdings Inc - Does Not Anticipate New Equity Raise for Purchase - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627283793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627283793?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:31","pubTimestamp":1776249078,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0BG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626058920","title":"Aspire Biopharma Hldgs Q4 EPS $(1.84) Down From $(1.10) YoY, Sales $4.261K Up From $0 YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2626058920","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626058920?lang=en_us&edition=fundamental","pubTime":"2026-04-09 06:00","pubTimestamp":1775685657,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(1.84) per share. This is a 67.27 percent decrease over losses of $(1.10) per share from the same period last year.  The company reported $4.261 thousand","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/51720943/aspire-biopharma-hldgs-q4-eps-1-84-down-from-1-10-yoy-sales-4-261k-up-from-0-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Aspire Biopharma Hldgs Q4 EPS $(1.84) Down From $(1.10) YoY, Sales $4.261K Up From $0 YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620247254","title":"Aspire Biopharma unit Buzz Bomb Caffeine signs national retail distribution deal with TruLife","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247254?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:02","pubTimestamp":1773921732,"startTime":"0","endTime":"0","summary":"Aspire Biopharma’s wholly owned unit Buzz Bomb Caffeine Company reached an agreement with TruLife Distribution for TruLife to manage sales, distribution and merchandising of BUZZ BOMB to retailers nationwide.The arrangement targets expansion into natural, organic, specialty and mass-merchandiser retail channels.BUZZ BOMB is sold as single-serving stick packs containing 50 mg of caffeine in a dry powder intended for under-the-tongue use.Kraig Higginson and Brian Gould commented on the agreement.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL5SyJFg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620422858","title":"Buzz Bomb Caffeine Company names John Choe Western Sales Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2620422858","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620422858?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:31","pubTimestamp":1773750666,"startTime":"0","endTime":"0","summary":"Buzz Bomb Caffeine, a wholly owned subsidiary of Aspire Biopharma, appointed John Choe as Western Sales Director. Choe previously served as a district manager at Yerbaé from 2016 to 2025. Yerbaé reported a 70% increase in overall sales during Choe’s tenure.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLbsN8br:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618314211","title":"Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Showcases BUZZ BOMB at HFA Show 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618314211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618314211?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:00","pubTimestamp":1773316848,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc.’s wholly owned subsidiary, Buzz Bomb Caffeine Company, will showcase its flagship BUZZ BOMB caffeine product in the New Product Zone at The Health & Fitness Show 2026 in San Diego on March 16-18. BUZZ BOMB is a 50mg caffeine dry powder in single-serving stick packs designed for under-the-tongue use.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL72Hsf1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618953981","title":"Aspire Biopharma launches BUZZ BOMB Covenience Store Pack","url":"https://stock-news.laohu8.com/highlight/detail?id=2618953981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618953981?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:51","pubTimestamp":1773147097,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) Holdings is expanding its retail footprint with the launch of the BUZZ BOMB Convenience Store Pack. The lineup includes the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-launches-buzz-bomb-covenience-store-pack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-launches-buzz-bomb-covenience-store-pack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616715340","title":"Aspire Biopharma Partners With Microsize on Sublingual Alprazolam Powder Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2616715340","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616715340?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:01","pubTimestamp":1772542870,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. has partnered with Microsize to accelerate development of a patent-pending, rapid-delivery sublingual powder formulation of alprazolam aimed at faster, more predictable anxiety relief than traditional tablets. The collaboration will leverage Microsize’s particle engineering and micronization capabilities, with Aspire targeting a Phase 1 clinical trial in mid-2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL5c4gdD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614877030","title":"Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Posts Record Social Media Growth and Sales Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2614877030","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614877030?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:30","pubTimestamp":1772026233,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc.’s wholly owned subsidiary, Buzz Bomb Caffeine Company, reported record social media growth and a surge in online revenue following its sponsorship of ultra-marathoner Ashley Paulson at the 2026 Jackpot Ultra Running Festival. Buzz Bomb said its content topped 400,000 views in 48 hours after Paulson set a women’s world record in the USATF 100-Mile Road Championship, and highlighted its 50mg caffeine stick-pack products offered in four flavors.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLdKlbd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aspirebiolabs.com","stockEarnings":[{"period":"1week","weight":-0.7456},{"period":"1month","weight":-0.6143},{"period":"3month","weight":-0.878},{"period":"6month","weight":-0.9802},{"period":"1year","weight":-0.9881},{"period":"ytd","weight":-0.9489}],"compareEarnings":[{"period":"1week","weight":0.0452},{"period":"1month","weight":0.0736},{"period":"3month","weight":0.0267},{"period":"6month","weight":0.0689},{"period":"1year","weight":0.349},{"period":"ytd","weight":0.0414}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PowerUp Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on video gaming, gaming adjacent, and metaverse businesses. PowerUp Acquisition Corp. was incorporated in 2021 and is based in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":-0.11488},{"month":2,"riseRate":0.5,"avgChangeRate":-0.304631},{"month":3,"riseRate":0.25,"avgChangeRate":-0.216086},{"month":4,"riseRate":0.5,"avgChangeRate":-0.249175},{"month":5,"riseRate":0.5,"avgChangeRate":0.002353},{"month":6,"riseRate":0.75,"avgChangeRate":-0.091962},{"month":7,"riseRate":0.75,"avgChangeRate":0.106788},{"month":8,"riseRate":0.75,"avgChangeRate":0.136896},{"month":9,"riseRate":0.5,"avgChangeRate":-0.137877},{"month":10,"riseRate":0.75,"avgChangeRate":0.199866},{"month":11,"riseRate":0.5,"avgChangeRate":-0.177747},{"month":12,"riseRate":1,"avgChangeRate":0.063987}],"exchange":"NASDAQ","name":"Aspire Biopharma Holdings Inc.","nameEN":"Aspire Biopharma Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Aspire Biopharma Holdings Inc.(ASBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Aspire Biopharma Holdings Inc.,ASBP,Aspire Biopharma Holdings Inc.股票,Aspire Biopharma Holdings Inc.股票老虎,Aspire Biopharma Holdings Inc.股票老虎国际,Aspire Biopharma Holdings Inc.行情,Aspire Biopharma Holdings Inc.股票行情,Aspire Biopharma Holdings Inc.股价,Aspire Biopharma Holdings Inc.股市,Aspire Biopharma Holdings Inc.股票价格,Aspire Biopharma Holdings Inc.股票交易,Aspire Biopharma Holdings Inc.股票购买,Aspire Biopharma Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aspire Biopharma Holdings Inc.(ASBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Aspire Biopharma Holdings Inc.(ASBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction